Bryn Martin

Dr. Martin serves as Vice President of Research, Precision Delivery and Cerebrospinal Fluid Sciences at Alcyone Therapeutics. In this role, he is responsible for overseeing a multidisciplinary research team focused on the advancement of the Alcyone Precision Delivery portfolio. This team specializes in the application of engineering principles to transform targeted CNS drug delivery and interacts across Alcyone Therapeutics’ early pre-clinical to clinical programs.

Dr. Martin has 20 years of experience in cerebrospinal fluid mechanics and physiology, has co-authored/authored over 60 peer-reviewed journal publications and book chapters in the field, and currently serves as Associate Editor of Fluids and Barriers of the CNS (Springer/Nature). Prior to joining Alcyone Therapeutics, Dr. Martin earned the rank of Associate Professor of Chemical and Biological Engineering at University of Idaho and served as Principal Investigator for research funded by National Institute of Health (NIH), National Aeronautics and Space Administration (NASA), National Science Foundation (NSF), industry (such as Genentech, Biogen, Voyager Therapeutics and others) and foundations (such as the American Syringomyelia and Chiari Alliance Project). Dr. Martin has also served as a consultant for 10+ years to the medtech and pharma sectors in the areas of medical devices and CNS drug delivery. He completed his postdoctoral fellowship in bioengineering and biomechanical engineering at the Swiss Federal Institute of Technology under Professor N. Stergiopulos and served as the first Director of the Conquer Chiari Research Center at The University of Akron. Dr. Martin earned a Ph.D. in mechanical engineering from the University of Illinois at Chicago.